Kirurgian vastuualue

Julkaisut 2017
Publications 2017

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Auvinen A et al. A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.
2 Azzouzi A et al. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
3 Beer T et al. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.
4 Brunner C et al. Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.
5 Donas K et al. Classification of Chimney EVAR-Related Endoleaks: Insights From the PERICLES Registry.
6 Eskelinen T et al. Components of metabolic syndrome and prognosis of renal cell cancer.
7 Fizazi K et al. Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial.
8 Fizazi K et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
9 Haring A et al. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
10 Harju J et al. Determination of saturation, heart rate, and respiratory rate at forearm using a Nellcor™ forehead SpO2-saturation sensor.
11 Hinkka T et al. Syöpäsairauksien endovaskulaariset ja perkutaaniset hoidot.
12 Ijäs P et al. Haptoglobin Hp2 Variant Promotes Premature Cardiovascular Death in Stroke Survivors.
13 Jämsä P et al. Risk factors associated with acute kidney injury in a cohort of 20,575 arthroplasty patients.
14 Kaipia A, Riikonen J. Contemporary and past challenges of prostate cancer diagnostics.
15 Kallio J et al. Resistin and interleukin-6 as predictive factors for recurrence and long-term prognosis in renal cell .
16 Khan N et al. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery.
17 Kilpeläinen T et al. Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer.
18 Kinnunen PTT et al. Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.
19 Kivinummi K et al. The expression of AURKA is androgen regulated in castration-resistant prostate cancer.
20 Kääriäinen M et al. Greater Success of Primary Fascial Closure of the Open Abdomen: A Retrospective Study Analyzing Applied Surgical Techniques, Success of Fascial Closure, and Variables Affecting the Results.
21 Lauronen S et al. Thermal suit in preventing unintentional intraoperative hypothermia during general anaesthesia: a randomized controlled trial.
22 Murtola J et al. Outcomes of Prostate Cancer Screening by 5a-Reductase Inhibitor Use.
23 Murtola T et al. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
24 Na R et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
25 Nevalainen J et al. What explains the differences between centres in the European screening trial? A simulation study.
26 Niemi RJ et al. Urinary Polyamines as Biomarkers for Ovarian Cancer.
27 Nuotio M et al. Iäkkäiden virtsaamisvaivat ja niiden hoito.
28 Nygård L et al. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
29 Oksala N et al. Synergistic Expression of Histone Deacetylase 9 and Matrix Metalloproteinase 12 in M4 Macrophages in Advanced Carotid Plaques.
30 Olesen S et al. The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort.
31 Peltokangas M et al. Combining finger and toe photoplethysmograms for the detection of atherosclerosis.
32 Peltokangas M et al. Age Dependence of Arterial Pulse Wave Parameters Extracted From Dynamic Blood Pressure and Blood Volume Pulse Waves.
33 Rade M et al. Reduced Spinal Cord Movement With the Straight Leg Raise Test in Patients With Lumbar Intervertebral Disc Herniation.
34 Rinne P et al. Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages.
35 Saarinen J. Alaraajojen pintalakimoiden kajoava hoito.
36 Seppälä I et al. The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis.
37 Seppänen L et al. Enhancing productive reflection in robotic surgery: Cross self-confrontation as a developmental method for learning interpretativeness in a digitalized era work.
38 Seppänen L et al. Encourager la réflexion en chirurgie robotique .
39 Sulkava M et al. Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques - Tampere Vascular Study.
40 Sulkava M et al. Differentially expressed genes and canonical pathways in the ascending thoracic aortic aneurysm - The Tampere Vascular Study.
41 Tammela T. Virtsasuihkun heikkous.
42 Tammela T. Virtsaumpi.
43 Tammela T. Akuutti bakteeriperäinen eturauhastulehtus.
44 Tammela T. Krooninen eturauhastulehdus.
45 Tammela T. Eturauhasen liikakasvu.
46 Tammela T. Eturauhassyöpä.
47 Tammela T et al. An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.
48 Urbanucci A et al. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.
49 Veskimäe E et al. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
50 Väänänen T et al. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
51 Wettstein MS et al. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
52 Witjes J et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
Julkaisutietokanta 20.6.2018 Publications Data Base 20.6.2018